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https://doi.org/10.1016/j.stemcr.2020.11.005SUMMARYCellular identity is ultimately dictated by the interaction of transcription factors with regulatory elements (REs) to control gene expres-
sion. Advances in epigenome profiling techniques have significantly increased our understanding of cell-specific utilization of REs. How-
ever, it remains difficult to dissect themajority of factors that interact with these REs due to the lack of appropriate techniques. Therefore,
we developed TINC: TALE-mediated isolation of nuclear chromatin.Using this newmethod,we interrogated the protein complex formed
at the Nanog promoter in embryonic stem cells (ESCs) and identified many known and previously unknown interactors, including
RCOR2. Further interrogation of the role of RCOR2 in ESCs revealed its involvement in the repression of lineage genes and the fine-tun-
ing of pluripotency genes. Consequently, using theNanogpromoter as a paradigm,we demonstrated the power of TINC to provide insight
into the molecular makeup of specific transcriptional complexes at individual REs as well as into cellular identity control in general.INTRODUCTION
Pluripotent stemcells (PSCs) carry immense therapeutic po-
tential as they canproduce any cell typeof thebody and can
self-renew indefinitely. The twomost common in vitro PSCs
are blastocyst-derived embryonic stem cells (ESCs) (Kauf-
man et al., 1983; Martin 1981) and induced PSCs (iPSCs),
which are obtained from somatic cells through expression
of the transcription factors (TFs) OCT4, SOX2, KLF4, and
C-MYC (Takahashi et al., 2007; Takahashi and Yamanaka
2006). Together with OCT4 and SOX2, NANOG forms the
core transcriptional network in ESCs/iPSCs that mediates
expression of self-renewal and pluripotency genes and
repression of differentiation genes (Loh et al., 2006; Boyer
et al., 2005; Chen et al., 2008; Marson et al., 2008; Kim
et al., 2008). ESCs express Nanog heterogeneously and can
be maintained upon Nanog deletion, although they are dif-
ferentiation prone (Chambers et al., 2007). These NANOG
fluctuations seem to play a role in lineage commitment
with high levels impeding ESC differentiation (Abranches
et al., 2014; Chambers et al., 2003; Kalmar et al., 2009).
Like any gene, Nanog expression is regulated by TFs that
interact with regulatory elements (REs) and other factors.1246 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020 j ª 2020
This is an open access article under the CC BY-NC-ND license (http://creativAt least two REs control Nanog in ESCs: the promoter
and the 5 kb enhancer (Apostolou et al., 2013; Kagey et
al., 2010). NANOG binds to both of these REs (Chen et
al., 2008; Kim et al., 2008) and mediates positive
(Wu et al., 2006) and negative (Fidalgo et al., 2012; Navarro
et al., 2012) feedback loops. Positive transcriptional regula-
tion has been associated with binding of OCT4 and SOX2
to the Nanog promoter (Rodda et al., 2005). Conversely,
Nanog auto-repression has been linked to the interaction
of NANOG with ZFP281 and the NuRD repressor complex
(Fidalgo et al., 2012). Nevertheless, while some of the pro-
teins that occupy these REs are known, the full complex
composition remains largely elusive.
This knowledge gap is partly due to the difficulty in dis-
secting a specific regulatory complex. Chromatin immuno-
precipitation (ChIP) has been invaluable to study in vivo
DNA-protein interactions but only allows interrogation of
one factor at a time, and requires a priori candidates and
appropriate antibodies. Thus, being able to simultaneously
analyze an entire protein complex is extremely advanta-
geous but is challenging due to (1) a genomic region of
low abundance (e.g., two copies per cell) has to be targeted
specifically and (2) the interacting proteins have to beThe Authors.
ecommons.org/licenses/by-nc-nd/4.0/).
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ARID1A (Gatchalian et al. 2018)
BRD4 (Liu et al. 2014)
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OCT4 (Chen et al. 2008 , Kim et al. 2008)
RNF2 (Jacinto et al. 2015)
SOX2 (Chen et al. 2008 , Kim et al. 2008)
SUMO1 (Cossec et al. 2018)
SUMO2 (Cossec et al. 2018)
TET2 (Sardina et al. 2018)
TEX10 (Ding et al. 2015)
TFCP2L1 (TCFCP2L1) (Chen et al. 2008)
UTF1 (Galonska et al 2014)
ZFP281 (Wang et al. 2008)
KLF5 (Aksoy et al. 2014)
NANOG (Kim et al. 2008)
+
1) Transfect cells with
3xHA-tagged TALE
2) Prep for immunoprecipitation
    a) Fix cells with formaldehyde
    b) Isolate nuclei
    c) Enrich chromatin
    d) Shear chromatin
3) Purify target with anti-HA
agarose
5a) qPCR 5b) LC-MS/MS
4) Elute and reverse cross-linking
CDK9 (Whyte et al. 2013)
KAT8 (Li et al. 2012)
KDM4B (JMJD2B) (Das et al. 2014)
NELFA (Rahl et al. 2010)
NIPBL (Kagey et al. 2010)
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enriched efficiently (e.g., mass spectrometry [MS] analyzes
proteins without amplification).
Several groups have set out to overcome these limita-
tions by developing locus-specific isolation or proximity
labeling methods. These include methods based on nu-
cleic acid hybridization (Antão et al., 2012; Déjardin and
Kingston 2009; Ide and Dejardin 2015; Kennedy-Darling
et al., 2014) or DNA-binding proteins, such as LexA (By-
rum et al., 2012; Fujita and Fujii 2011), TetR (Pourfarzad
et al., 2013), Cas9 (Waldrip et al., 2014; Fujita and Fujii
2013; Gao et al., 2018; Schmidtmann et al., 2016; Tsui
et al., 2018; Qiu et al., 2019; Liu et al., 2017), or TALEs (By-
rum et al. 2013; Fang et al., 2018; Fujita et al., 2013).
Although nucleic acid hybridization-based approaches
pioneered the field, they require intensive optimization
(Antão et al., 2012; Déjardin and Kingston 2009; Ide and
Dejardin 2015), which might be why they have not yet
been widely adopted or translated to single-copy elements
in mammalian cells. To interrogate such challenging re-
gions, different groups have adapted the CRISPR-Cas9
technology (Fujita and Fujii 2013; Qiu et al., 2019; X.
Liu et al., 2020, 2017). Unlike TetR and LexA, CRISPR-
Cas9 does not require insertion of binding sites into the
target sequence and can be customized relatively easily.
However, there are increasing reports of high-frequency
off-targeting events by CRISPR-Cas9 (Fu et al., 2013;
Duan et al., 2014; Kuscu et al., 2014; Lin et al., 2014; X.
Wang et al., 2015; Liu et al., 2018), which in turn poten-
tially skew the results of such single-locus studies. Impor-
tantly, TALEs are associated with significantly lower off-
targeting than CRISPR-Cas9 (X. Wang et al., 2015).
Furthermore, evidence suggests that TALEs can be utilized
to enrich a specific locus from the complex mammalian
genome (Fang et al., 2018).
Taking advantage of these characteristics, we developed a
TALE-based method that allows isolation of a specific
genomic region from mammalian cells termed TINC
(TALE-mediated isolation of nuclear chromatin). UsingFigure 1. TINC Allows Isolation of the Nanog Regulatory Complex
(A) Schematic of the TINC method.
(B) Two TALEs were designed to bind upstream of the OCT4-SOX2 moti
5 kb Nanog enhancer are located in open chromatin, and ChIP-seq
(C) qRT-PCR of Nanog transcript levels (fold Gapdh) (mean ± SD; n =
(D) TINC-qPCR confirmed strong enrichment of the Nanog promoter ov
TALE2 (mean ± SD; n = 3 independent experiments, e.g., R1, R2, and
(E) Overlap of proteins isolated by TALE1 and TALE2 upon subtraction
(n = 3 independent experiments).
(F) Overlap of the intercept of proteins identified by TALE1 and TALE2 i
least two of the three replicates (i.e., TINC proteins) contained many
(G) ChIP-seq data processed by ChIP-Atlas (Oki et al., 2018) shown at
by ChIP-Atlas but not the original publication are marked with an aster
the ChIP-Atlas (red). The promoter (P) and the 5 kb enhancer (RE)
See also Figure S1 and Tables S1 and S2.
1248 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020TINC, we interrogated the regulatory complex formed at
the Nanog promoter in mouse ESCs.RESULTS
Development of TINC to Identify the Nanog
Regulatory Complex
To interrogate the protein complex formed at the Nanog
promoter in ESCs we developed and applied TINC (Fig-
ure 1A). In brief, cells expressing a 3xHA-tagged TALE de-
signed to bind to a region of interest are fixed and thenuclei
and chromatin are isolated before sonication. The target re-
gion is then isolated using affinity purification of the TALE,
and nucleic acids and proteins are further processed. To
minimize selection of proteins enriched through TALE
off-targeting, we performed TINC with two different TALEs
targeting theNanog promoter and considered only proteins
enriched by both TALEs as genuine binders. To that end,
four TALEs were designed (Figure S1A) and tested by ChIP-
qPCR to identify the most efficient TALEs (Figure S1B).
Consequently, TALE1 and TALE2 were selected (Figure 1B).
Importantly, ESCs stably expressing either TALE showed
unaltered Nanog expression (Figures 1C and S1C) and re-
tained their pluripotency potential (Figure S1D).
Next, TINC was performed with both TALEs in three in-
dependent experiments. As negative control, empty vec-
tor-transfected ESCs were used. The DNA isolated in each
TINC reaction was analyzed by qPCR, which indicated
comparable Nanog promoter enrichment efficiencies by
both TALEs (approximately 30-fold over background) (Fig-
ure 1D). To determine the genome-wide binding sites of
TALE1 and TALE2, two replicates were sequenced. This re-
vealed that TALE1 and TALE2 had 12 and 3 off-targets,
respectively (Figures S1E and S1F; Table S1), which is
considerably less than what had been shown for compara-
ble CRISPR-Cas9 approaches (Liu et al., 2020, 2017).
Importantly, this analysis also confirmed that the onlyfrom ESCs
f in the Nanog promoter. ATAC-seq shows that the promoter and the
indicates that both regions are targeted by OCT4 and SOX2.
6 independent experiments).
er the genomic background (Sox2 regulatory region 2) by TALE1 and
R3).
of proteins enriched unspecifically from the empty vector controls
n three TINC runs shown in Figure 1E. The 455 proteins present in at
of the previously published Nanog promoter binders.
the Nanog promoter. Proteins identified as Nanog promoter binders
isk. Below each BigWig track (black) are the respective peak calls by
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Figure 2. Characterization of the Proteins Identified at the Nanog Promoter in ESCs
(A) Protein class categories for all 455 TINC proteins. A total of 197 proteins were not assigned.
(B) Clustered GO biological processes and KEGG pathways enriched in the TINC protein dataset. Enrichment is thelog10(geometric mean)
of p-values of clustered terms.
(legend continued on next page)
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site co-bound by both TALEs is the Nanog promoter (Fig-
ure S1E). Hence, the protein content of each sample was
analyzed byMS. Upon subtraction of proteins also detected
in the negative controls, we obtained several hundred pro-
teins from each sample and an overlap of approximately
60% between proteins enriched by TALE1 and TALE2 (Fig-
ure 1E). Further comparative analyses of the proteins re-
vealed that 241 were present in all three and an additional
214 in two of the three replicates (Figure 1F; Table S1).
Importantly, these 455 proteins, hereafter referred to as
TINC proteins, contained 30 published binders (Figure 1F;
Tables S1 and S2). In addition, ChIP-Atlas, which processes
published ChIP sequencing (ChIP-seq) data via its own
pipeline and can hence identify binding events not de-
tected in the original publication (Oki et al., 2018),
confirmed Nanog promoter targeting by an additional 12
TINC proteins (Figure 1G; Tables S1 and S2). Notably,
TINC did not simply result in the detection of highly abun-
dant chromatin-associated proteins, but also in the specific
enrichment of lowly abundant candidates, which further
supports the validity and sensitivity of TINC (Figure S1G).
Altogether, this demonstrates that TINC enables interroga-
tion of specific regulatory complexes and has the power to
uncover hundreds of interacting proteins.
Analysis of the Nanog Regulatory Complex Reveals
Proteins with Different Functions
Enrichment analyses of the TINCproteins showed overrep-
resentation of nucleic acid and chromatin binders, tran-
scriptional regulators, and protein-modifying enzymes
with roles in cell cycle, DNA replication and repair, histone
modification, and stem cell regulation (Figures 2A and 2B).
In accordance, protein network analysis identified protein
clusters related tomany of these processes (Figure 2C; Table
S3). This shows that, while the cell cultures were not syn-
chronized and therefore proteins associated with various
stages of the cell cycle were detected, TINC identified a
large number of proteins related to transcriptional regula-
tion with a role in stem cell identity as expected from
Nanog.
The TINC proteins included 56 TFs and 101 epigenetic
modifiers (Figure S2A; Table S1).While the epigeneticmod-
ifiers were mainly associated with histone modifications
(Figure S2B), the TFs showed enrichment for various pro-(C) Protein-protein interaction network analysis and MCL clustering
enriched in the top ten clusters are displayed.
(D) Enrichedprocesses andpathways for TFs identified by TINC. Significan
(E) Overlap of the TINC proteins with the pluripotency regulatory net
three TINC replicates are depicted in red and proteins identified in two
node (protein) indicates the number of proteins interacting with tha
(F) KD of 37 TINC proteins resulted in a significant change in Nanog
See also Figure S2 and Table S3.
1250 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020cesses related to transcriptional regulation and mainte-
nance of pluripotency (Figure 2D). Intersection of the
TINC proteins with the previously defined pluripotency
regulatory network (Nefzger et al., 2017; Xu et al. 2013,
2014) revealed that 69 key network components form
part of the Nanog regulatory complex (Figures 2E and
S2C). We also identified ESRRB, SALL4, and NACC1 in
our TALE pull-downs; however, these key regulators were
also present in the negative controls (albeit with a lower
number of peptide spectrum matches) and were therefore
excluded from further analyses.
To determine the transcriptional output of the TINC pro-
teins, we utilized a published RNAi screen conductedwith a
Nanog-GFP reporter ESC line (Gingold et al., 2014). Inter-
estingly, while we identified 381 of the authors’ small inter-
fering RNA targets at theNanog promoter, knockdown (KD)
of only 23 resulted in a significant decrease in Nanog
expression, indicative of a role of these proteins in mainte-
nance of pluripotency (Figures 2F, S2D, and S2E).
Conversely, KDof 14 TINCproteins resulted in a significant
increase in Nanog expression, suggesting that these pro-
teins act as repressors of Nanog and might play a role in
silencing of this gene during differentiation (Figures 2F,
S2D, and S2E). Together, these results show that various
transcriptional regulators, including activators and repres-
sors, form part of the Nanog regulatory complex in ESCs.
Different Requirements for Nanog Regulatory
Complex Members in Pluripotency Acquisition and
Maintenance
Cellular reprogramming is driven by reconfiguration of the
epigenome, which leads to silencing of the somatic
network and activation of the pluripotency program
(Chronis et al., 2017; Knaupp et al., 2017; Maherali et al.,
2007; Polo et al., 2012). To determine which TINC proteins
are specific to pluripotency and hence upregulated during
reprogramming of mouse embryonic fibroblasts (MEFs)
into iPSCs, we performed differential gene expression
(DGE) analysis. DGE analysis revealed that 61% of the
TINC proteins are expressed significantly higher in iPSCs
(versus 8% in MEFs) and that many of the known Nanog
binders might not be pluripotency specific (Figure 3A).
Next, we selected proteins with a large change (e.g.,
RCOR2 and DNMT3L), an intermediate change (e.g.,of the TINC proteins. GO biological processes and KEGG pathways
ce cutoff q = 0.05 (Benjamini-Hochberg correction) is shown (x axis).
work (Fisher’s exact test, <2.2 3 1016). Proteins identified in all
out of the three TINC replicates are shown in orange. The size of the
t specific protein.





Figure 3. Interrogation of Novel Nanog Promoter Interactors Identified by TINC
(A) DGE analysis of TINC protein expression in iPSCs versus MEFs. Proteins selected for follow-up experiments are shown in red. Significance
cutoff false discovery rate (FDR) of 0.05 is shown (y axis).
(legend continued on next page)
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WDR76 and ZFP57), and no change (e.g., ATAXIN10 and
QRICH1) in DGE for further investigation. To overcome
the lack of ChIP antibodies, these six proteins as well as
the positive controls MYBL2 (Zhan et al., 2012) and
SOX2 were 3xHA tagged. This allowed us to confirm Nanog
promoter binding by the majority of these candidates (Fig-
ure 3B), further validating TINC as well as endorsing ChIP-
Atlas, which had identified ZFP57 as a Nanog binder (Fig-
ure 1G) while the original publication did not (Strogantsev
et al., 2015). To determine whether these proteins directly
control Nanog expression, we used small hairpin RNAs
(shRNAs) for which we obtained approximately 75% target
KD (Figures S3A and S3B). Depletion of several of these fac-
tors resulted in a change in ESC morphology, which was
most pronounced for Nanog and Rcor2 (Figure S3C). As
shown previously, KD of Nanog led to a considerable
amount of cell death (Chen et al.,2012), while loss of
Rcor2 triggered the cells to grow in a monolayer instead
of dome-shaped colonies (Figure S3C). Despite the
perceived morphological changes, only KD of Mybl2 and
Qrich1 resulted in a significant change in Nanog expression
(Figure 3C).
Analysis of TINC protein expression during MEF reprog-
ramming revealed that many are transiently or perma-
nently upregulated and that these proteins aremainly asso-
ciated with chromatin organization and transcriptional
regulation (Figures 3D, S3D, and S3E). Furthermore, 73%
of the TINC proteins, including the majority of our candi-
dates, are upregulated at the end of reprogramming and are
strongly correlated with Nanog expression (Figures 3E, 3F,
and S3D). Interestingly, while KD ofMybl2,Dnmt3l,Qrich1,
Wdr76, and Zfp57 resulted in a significant decrease in re-
programming efficiency, KD of Rcor2 led to a significant in-
crease (Figure 3G). Overall, these results suggest that many
of the proteins identified at the Nanog promoter in the
pluripotent state also play a role in establishing this state
during reprogramming.
Since it has previously been proposed that Rcor2 posi-
tively regulates MEF reprogramming (Yang et al., 2011),(B) ChIP-qPCR analysis for Nanog promoter enrichment by 3xHA-tagg
experiments). **p % 0.01 versus ESC control.
(C) qRT-PCR analysis of Nanog expression upon shRNA-mediated KD of
Ywhaz (mean ± SD; n = 3 independent experiments). *p % 0.05 and
(D) Heatmap showing standardized TINC protein expression during
indicate that the proteins are a part of the pluripotency network from F
two out of the three TINC replicates.
(E) Distribution of Pearson’s correlation coefficients of TINC protein
programming.
(F) Standardized gene expression dynamics of the TINC proteins durin
highlighted and their reprogramming correlation coefficients to Nano
(G) MEF reprogramming efficiency upon shRNA-mediated KD of select
three independent experiments).
See also Figure S3.
1252 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020we set out to further explore its role during this conversion.
Using a different reprogramming system (OKMS instead of
OKSM) and two alternative Rcor2 shRNAs individually and
combined, we observed the same trend (Figures S3F and
S3G). Flow cytometric analysis during reprogramming re-
vealed that the total number of cells en route to becoming
iPSCs (SSEA1+) approximately doubled due to an overall in-
crease in cell numbers rather than an increase in the per-
centage of SSEA1+ cells (Figures S3H–S3J). Conversely,
overexpression of Rcor2 led to a decrease in iPSC formation,
although non-significant, which indicates that RCOR2
may impair pluripotency acquisition (Figure S3K).
RCOR2 Is a Component of the Pluripotency
Regulatory Network
To gain further insight into the targets and partners of
RCOR2, we first performed ChIP-seq, which revealed
extensive binding to intergenic and intronic regions in
ESCs (Figure S4A; Table S4). Approximately 13% of the
binding sites of RCOR2 are located in promoter regions,
including the promoters of Nanog, Oct4, and Sox2 (Figures
4A and S4A). Indeed, the majority of RCOR2 target genes
are expressed (e.g., 8,514) and associated with various cell
division- and pluripotency-related functions, while low or
unexpressed targets (e.g., 3,030) are mainly associated
with neuronal processes (Figure S4B). Intersection of the
genome-wide binding sites and target genes of RCOR2 re-
vealed extensive co-occupancy of RCOR2 with NANOG,
OCT4, or SOX2 targets (Figures 4B and S4C; Table S4). A hy-
pergeometric test validated that indeed RCOR2 co-occu-
pancy with OCT4 (p = 0), SOX2 (p = 1.01664 3 10310),
or NANOG (p = 3.96871 3 10246) targets is highly signif-
icant. Notably, genes occupied by all four factors have the
highest median expression, include many key pluripo-
tency regulators, and are enriched for various develop-
mental processes (Figures 4B, 4C, S4D). In agreement,
motif enrichment analysis showed several pluripotency
TF motifs, including OCT4, SOX2, and NANOG in ESC en-
hancers (Figure 4D). In line with the observed binding ofed factors stably expressed in ESCs (mean ± SD; n = 3 independent
selected factors and normalized to the levels of housekeeping gene
**p % 0.01 versus non-targeting (NT) shRNA control.
MEF reprogramming (grouped by protein categories). Black bars
igure 2E and blue bars whether they were identified in all three or in
expression in relation to the expression of Nanog during MEF re-
g MEF reprogramming. Targets selected for further investigation are
g are shown in brackets.
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RCOR2 CoIP DGE iPSC vs MEF:
identified by TINC
Figure 4. RCOR2 Is Part of the Pluripotency Regulatory Network in ESCs
(A) Tracks depicting RCOR2 ChIP-seq at Nanog, Oct4, and Sox2. Promoters (P) and known regulatory elements (REs), including the Oct4
distal (DE) and proximal (PE) enhancers are indicated in orange. ATAC-seq shows regions of open chromatin.
(B) Intersection of NANOG, SOX2, OCT4, and RCOR2 target genes in ESCs. Expressed targets (red), repressed targets (blue), and the
expression distributions are shown.
(C) Proteins of the pluripotency regulatory network are colored indicative of whether they are targets of NANOG (N), SOX2 (S), OCT4 (O),
and/or RCOR2 (R). The size of the node (protein) indicates the number of proteins interacting with that specific protein.
(D) Motif enrichment analysis of RCOR2 ChIP-seq peaks. Where a point is present, a significant enrichment for the motif (x axis) was found
at all sites, pluripotency enhancers, or at other sites (non-pluripotency enhancers) occupied by RCOR2 (y axis). Point size represents the
proportion of sequences featuring the motif and color gradient the enrichment significance.
(legend continued on next page)
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RCOR2 to neuronal genes (Figure S4B), we obtained motif
enrichment for REST, a repressor associated with silencing
of neuronal genes in non-neuronal cells (Chong et al.,
1995; Schoenherr and Anderson 1995).
Next, to determine interactors of RCOR2, we conducted
co-immunoprecipitations (CoIPs), which identified 368
proteins (Figures 4E and 4F; Table S4). Among those were
79 transcriptional regulators predominantly associated
with histone modifications, including LSD1, which had
previously been found to interact with RCOR2 in pluripo-
tent and neural cells (Yang et al., 2011; Wang et al., 2016)
(Figure S4E; Table S4). Upon close examination of the
TINC results, we noticed that LSD1 had also been excluded
due to traces in the negative controls. LSD1 forms part of
various complexes, including CoREST/REST and NuRD
(Andrés et al., 1999; Foster et al., 2010; Mosammaparast
and Shi 2010). Notably, while RCOR2 CoIP resulted in
enrichment of various NuRD complex components, CoR-
EST and REST were not detected (Figures 4E; Table S4).
Furthermore, integration of published ChIP-seq data
confirmed extensive co-binding of RCOR2 and LSD1
within ESCs (Figures S4F and S4G; Table S4). Interestingly,
while some of these sites are also bound by REST and CoR-
EST or, to a larger extent by NuRD complex components,
many sites are exclusively targeted by LSD1 and RCOR2
(Figures S4F and S4G). Notably, ESC enhancers did not
show major occupancy by CoREST or REST but extensive
targeting by LSD1, RCOR2, and NuRD members (Fig-
ure S4H). Inhibition of LSD1 has previously been shown
to promote iPSC formation (Sun et al., 2016). Importantly,
concomitant inhibition of LSD1 alleviated the inhibitory
effect of RCOR2 overexpression, suggesting that RCOR2
exerts its function at least partly via LSD1 during reprog-
ramming (Figure S3K). Together, our results revealed that
RCOR2 binds extensively in ESCs and forms part of various
regulatory complexes, including, LSD1, NuRD, and CoR-
EST/REST complexes.
RCOR2 Is Required for Efficient ESC Differentiation
To further investigate the role of RCOR2, we created a
CRISPR-Cas9 knockout (KO) ESC line (Figure 5A). Rcor2
depletion was confirmed at the DNA, RNA, and protein
levels (Figures S5A–S5C). Notably, Rcor2 KO resulted in
similar morphological changes as observed upon shRNA-
mediated KD (Figures S3C and 5A). Subsequent RNA
sequencing of the Rcor2 KO line revealed transcriptional(E) Volcano plot showing the enrichment of proteins copurified by
replicates). Lines indicate the threshold above which proteins are sig
shown in red and NuRD complex components and interactors are indi
(F) DGE analysis of TINC protein expression in iPSCs versus MEFs. Pro
nificance cutoff FDR = 0.05 is shown (y axis).
See also Figure S4 and Table S4.
1254 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020deregulation of 1,977 genes, approximately 74% of which
are RCOR2 targets (Figure 5B; Table S4). Interestingly,
many RCOR2 targets, which showed transcriptional dereg-
ulation upon Rcor2 KOwere related to cell cycle and cell di-
vision (Figure S5D). In agreement, growth rate analyses re-
vealed a significant decrease in ESC andMEF doubling time
upon Rcor2 depletion, suggesting that RCOR2 is a negative
regulator of cell-cycle progression (Figure S5E). Further-
more, this analysis revealed that RCOR2 is involved in tran-
scriptional regulation of various pluripotency network
components, including repression of Oct4 and Nanog (Fig-
ures 5C and S5F).
Next, to assess the possible role of RCOR2 during differen-
tiation,we subjected theKOandwild-type (WT) ESC lines to
an embryoid body (EB) formation assay. Rcor2 KO EBs
showed a considerable amount of cell death andwere signif-
icantly smaller than WT EBs (Figures 5D and 5E). Further-
more, differentiation into cardiac cells revealed that WT
EBs generated beating colonies, while Rcor2 KO EBs did not
(Figures 5F;Video S1). Importantly, qRT-PCR revealed persis-
tent expression of pluripotency genes in the Rcor2 KO EBs
(Figure 5G). In agreementwith the EB assay, teratoma assays
showed limited growth for Rcor2 KO ESCs in vivo. Although
Rcor2 KO ESCs were able to eventually form teratomas with
cell types from all three germ layers, it took an additional
5 days to reach a palpable size (Figures S5G–S5H). Together,
these data suggest that RCOR2 plays a role in downregulat-
ing pluripotency genes during differentiation.DISCUSSION
We developed TINC, which allows isolation of a specific
genomic locus and applied it to interrogate the protein
complex formed at the Nanog promoter in ESCs. To reduce
the number of false positives, two TALEs were utilized and
only proteins enriched by both were considered as true
binders. Although our experimental setup allowed us to
confirm the reproducibility of TINC, it prevented the usage
of label-free quantitative software packages (such as Max-
Quant [Cox and Mann 2008]). In future, such quantitative
approaches could be used to decrease the amount of false
negatives (e.g., despite higher peptide spectrum matches
in the TALE samples LSD1, ESRRB, SALL4, and NACC1
had been excluded due to trace levels in the negative
controls).RCOR2 in comparison with the negative control (n = 3 technical
nificantly enriched (FDR < 0.05 and log2FC > 1). TINC proteins are
cated.
teins also detected in RCOR2 CoIPs are colored in turquoise. Sig-

























































































































































Figure 5. Rcor2 KO ESCs Have a Differentiation Impairment
(A) Representative bright-field images of WT and Rcor2 KO ESCs. Scale bar, 250 mm.
(B) DGE analysis of Rcor2 KO versus WT ESCs separated into genes occupied by RCOR2 and genes that are not RCOR2 targets (y axis). Red
indicates genes that show an increase and blue indicates genes that show a decrease in expression upon Rcor2 KO (n = 2 independent
experiments).
(C) Proteins of the pluripotency regulatory network colored according to their change in expression upon Rcor2 KO.
(D) Representative bright-field images of WT and Rcor2 KO EBs on days 4 and 7 of culture. Scale bar, 250 mm.
(E) EB sizes on day 4 (D4) and day 7 (D7) of culture as measured by diameter (mean ± SD; nR 8 EBs, representative of two independent
experiments).
(F) Frequency of contractile cardiac colonies obtained in an EB cardiac differentiation assay (mean ± SD; n = 3 technical replicates).
(G) qRT-PCR analysis to examine pluripotency marker expression in Rcor2 KO EBs. Transcript levels were normalized to the levels of the
housekeeping gene Ywhaz and then to corresponding WT EBs (mean ± SD; n = 3 technical replicates, representative of 2 independent
experiments).
See also Figure S5 and Table S4 and Video S1.TINC allowed us to identify 455 proteins at the Nanog
promoter in ESCs (i.e., TINC proteins). While only a frac-
tion of these proteins were known binders, many had pre-viously been associated with a role in pluripotency. For
example, TINC revealed direct Nanog promoter targeting
by JMJD1A, RCOR2, and ZFP57, all of which had beenStem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020 1255
linked to a change inNanog expression uponKD (Loh et al.,
2007; Riso et al., 2016; Yang et al., 2011). Many of the TINC
proteins are upregulated during reprogramming and KD of
several of them impaired iPSC formation, suggesting that
they play a role in establishing the pluripotent state.
Conversely, KD of Rcor2 resulted in a significant increase
in colony numbers. Further investigation revealed that
Rcor2 depletion leads to increased Nanog levels, a decrease
in MEF/ESC doubling time, and increased cell numbers;
all processes that facilitate reprogramming. Furthermore,
our data suggest that RCOR2 mediates its function at least
partially through an interaction with LSD1, inhibition of
which also promotes cellular reprogramming (Sun et al.,
2016). We validated our result in different reprogramming
systems; however, since previous work observed RCOR2 as
a positive regulator of cellular reprogramming (Yang et al.,
2011), its mechanisms might be expression level and/or
reprogramming system dependent. Further studies may
need to be performed to address these differences in
observations.
Interestingly, RCOR2 seems to be non-essential for ESC
maintenance despite occupying many expressed genes.
Indeed, approximately 70% of its targets are transcrip-
tionally active and are associated with maintenance of
pluripotency, while inactive RCOR2 targets are enriched
for various neuron-related functions. Similarly, REST has
been implicated in the repression of neuronal genes in
non-neuronal cells (Chong et al., 1995; Schoenherr and
Anderson 1995). Importantly, our data revealed that
RCOR2 forms part of the REST complex in ESCs and oc-
cupies approximately 40% of REST binding sites. While
many of these regions are also targeted by LSD1, they ac-
count for less than 5% of RCOR2 or LSD1 binding sites.
Notably, RCOR2 and LSD1 have a similar number of tar-
gets (approximately 12,000 genes), over 70% of which are
shared. This suggests that, while in ESCs RCOR2 forms
part of the REST complex, it also interacts with alterna-
tive LSD1 complexes, including NuRD. Previous work
has shown that LSD1 is significantly more likely to
occupy pluripotency enhancers with NuRD complex
components than the CoREST/REST complex (Whyte
et al., 2018) and our data revealed that RCOR2 does so
too. This suggests that RCOR2 may be involved in the
fine-tuning of pluripotency genes and the repression of
lineage-specific genes in ESCs as part of various LSD1
complexes.
Similar to RCOR2, LSD1 does not play amajor role in ESC
maintenance; however, LSD1 inhibition leads to incom-
plete repression of many ESC genes during differentiation
(Whyte et al., 2018). Similarly, Rcor2 KO ESCs were charac-
terized by an inefficiency to form EBs, which in turn
showed prolonged expression of pluripotency genes, as
well as poor differentiation potential in vitro and in vivo.1256 Stem Cell Reports j Vol. 15 j 1246–1259 j December 8, 2020This further supports a functional interaction of LSD1
and RCOR2 during pluripotency exit.
In summary, TINC allowed us to interrogate the regulato-
ry complex formed at the Nanog promoter in an unbiased
manner and revealed that transcriptional regulation of
this TF occurs at many different levels. Furthermore, our
data suggest that many factors that aid in downregulating
Nanog during differentiation, such as RCOR2, already
reside at its promoter in the pluripotent state. Together,
this implies a highly complex and coordinated interplay
of multiple factors that ensures the correct NANOG levels
so that ESCs can self-renew and exert their full differentia-
tion potential, rapidly and on-cue.EXPERIMENTAL PROCEDURES
Generation of TALE-Expressing ESC Lines
The Nanog targeting TALEs were created as described (Briggs et al.,
2012) and stable ESC lines were generated as described in the Sup-
plemental Information.
TINC
Approximately 1 3 109 cells were fixed with formaldehyde, and
nuclei and chromatin were isolated as described previously
(Knaupp et al., 2017; Kustatscher et al., 2014). The chromatin
was then sonicated using a Bioruptor NextGen device (Diagenode)
and the TALEs immunoprecipitated using Anti-HA Agarose Resin
(Pierce 26182) as described in the Supplemental Information.
Nanog promoter enrichment was confirmed by qPCR before liquid
chromatography-tandem MS (LC-MS/MS) analysis.
LC-MS/MS Analysis of Proteins Enriched by TINC
To determine the proteins isolated by TINC, in-gel tryptic digests
were analyzed using an Orbitrap Fusion Tribrid mass spectrometer
(Thermo Fisher Scientific) as described in the Supplemental
Information.
All other experimental procedures are detailed in Supplemental
Information.
Data and Code Availability
The accession numbers for the data reported in this paper are avail-
able in GEO: GSE160816 and ProteomeXchange: PXD022088
(Perez-Riverol et al., 2019).
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.11.005.
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